Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.

The oncologist(2023)

引用 1|浏览23
暂无评分
摘要
Stakeholders should look to hematologic, pancreatic, and industry-funded cancer trials as exemplars of female participant representation and consider female representation when interpreting trial results.
更多
查看译文
关键词
female participant representation,oncology clinical trials,participation to prevalence ratio
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要